There is currently a lack of available treatments that can prevent or modify the progression of neurodegenerative disorders like Alzheimer's disease and Parkinson's disease, which affect millions of people in Europe. Despite robust research efforts to accelerate biomarker discovery, there are few secure, accessible ways for clinical samples and data to be discovered and shared within the research community.
'Alzheimer's and Parkinson's cost millions of lives and will create an estimated economic burden in Europe of €267 billion by 2030,' said project co-Coordinator Pieter Jelle Visser, Associate Professor at the University of Maastricht. 'EPND will answer this massive challenge with a solution on the same scale, bringing together teams, samples and data from across the continent.'
Professor Michele Hu (Nuffield Department of Clinical Neurosciences) is a Co-Investigator on the project, and UK lead for the Parkinson's disease biomarker collection.
Read the full story on the Nuffield Department of Clinical Neurosciences website